Target selection: Difference between revisions
Jump to navigation
Jump to search
JohnEverett (talk | contribs) No edit summary |
JohnEverett (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
As part of the NIH funded PSI-2 project, the NESG dedicates 70% of its resources to the determination | As part of the NIH funded PSI-2 project, the NESG dedicates 70% of its resources to the determination of targeted families assigned by the PSI BIG group, <br>30% to targets nominated by the accademic community and 30% to its own biomedically oriented projects such as key proteins in Human cancer interaction<br>networks and bacterial lipoproteins. | ||
Revision as of 16:41, 1 December 2009
As part of the NIH funded PSI-2 project, the NESG dedicates 70% of its resources to the determination of targeted families assigned by the PSI BIG group,
30% to targets nominated by the accademic community and 30% to its own biomedically oriented projects such as key proteins in Human cancer interaction
networks and bacterial lipoproteins.